cve.bz

CVE-2022-45611

9.8 criticalEPSS 1.2%

Critical (9.8) in fresenius-kabi pharmahelp firmware. EPSS 1.2% chance of exploitation in the next 30 days.

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Severity

CVSS 3.1

9.8 critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
EPSS
1.2% chance of exploitation in the next 30 days; higher than 67% of CVEs (scores of 2026-10-31)
CWE
CWE-522
Published
Modified
Record from
the NVD, synced

Affected

References

Check your stackJSON